2007 - a special anniversary year for Dräger

Drägerwerk AG100 years ago in October 1907, company founder, Johann Heinrich Dräger, was awarded a patent for the Pulmotor, the first mobile short-term respirator. This marked the birth of ventilation technology development at Dräger. Simple, reliable, and extremely effective, the apparatus - transported in a wooden casket - quickly became a standard piece of equipment used by rescue services throughout Germany.

It all began early in the 20th century, when, on a trip to England, Johann Heinrich Dräger witnessed a young man being pulled out the Thames and resuscitated using the traditional Schaeffer method. Still in London, Dräger then produced some initial sketches. Upon returning to Lübeck, he began developing a technical solution for a resuscitation machine. After a few more modifications, the result was "Dräger's Pulmotor, the first automatic oxygen resuscitation machine for artificial respiration", manufactured in the factory and construction institute for oxygen apparatus known at the time as Drägerwerk in Lübeck, Germany. In his memoirs, Johann Heinrich Dräger spoke of the Pulmotor as having enabled well over 1,000 officially attested resuscitations by March 1, 1917.

Successful attempts at resuscitating miners poisoned by carbon monoxide, for example, paid testament to the success of the oxygen machine just a short time after its market launch in 1908 - in defiance of the skeptics of positive pressure respiration. Dräger consequently started serial production which, even at that time, proved extremely successful in the United States. The first Dräger company on US soil was founded in the US in 1907, too: at 11 Broadway in New York City; shortly afterwards, the company was moved to Pittsburgh, PA, and renamed Draeger Oxygen Apparatus Company. Internationality and innovativeness have a long tradition at Dräger.

In the US, the Pulmotor respirator was bought mainly to equip rescue teams of mining companies (mine rescuers) and fire departments, hence Dräger's legendary reputation for breathing apparatus in the US: mine rescuers equipped with Dräger apparatus were known as Draegermen.

The Oxylog product family, which is still going strong today, superseded the successful Pulmotor in 1978. After the first applications of the Iron Lung in the fifties, long-term positive pressure ventilation was introduced. Today, this is fulfilled by the intensive care ventilators of the Evita family. All of these devices are based on the technical specifications of the Pulmotor. In fact, advancements in this technical innovation from the beginning of the 20th century are now not only used for emergency and long-term ventilation, but also in anesthesia and for home care.

For further information, please visit:
http://www.draeger.com

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...